| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.11 | 0.6 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.1 | 0.6 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |